📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib. (2018)

First Author: Callegari D

Attributed to: Adaptive Multi-Resolution Massively-Multicore Hybrid Dynamics funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c7sc04761d

PubMed Identifier: 29732058

Publication URI: http://europepmc.org/abstract/MED/29732058

Type: Journal Article/Review

Volume: 9

Parent Publication: Chemical science

Issue: 10

ISSN: 2041-6520